VALVOLINE INC. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
VALVOLINE INC. (VVV) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $69.10 million for the 12-month period ending 2025-09-30, per its 10-K filed 2025-11-21.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2025-11-21
- VALVOLINE INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2020-09-30 was $7.00M.
- VALVOLINE INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2020-06-30 was $14.00M.
- VALVOLINE INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2020-03-31 was $13.00M.
- VALVOLINE INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2019-12-31 was $15.00M.
- VALVOLINE INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $69.10M, a 8.99% increase from fiscal 2024.
- VALVOLINE INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $63.40M, a 36.64% increase from fiscal 2023.
- VALVOLINE INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $46.40M, a 0.85% decline from fiscal 2022.
- VALVOLINE INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $46.80M, a 25.71% decline from fiscal 2021.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month as first filed |
|---|---|---|---|---|---|
| 2025-09-30 | $69.10M 10-K · filed 2025-11-21 | ||||
| 2024-09-30 | $63.40M 10-K · filed 2025-11-21 | ||||
| 2023-09-30 | $46.40M 10-K · filed 2024-11-22 | ||||
| 2022-09-30 | $46.80M 10-K · filed 2023-11-20 | ||||
| 2021-09-30 | $63.00M 10-K/A · filed 2022-12-02 | $83.00M 10-K · filed 2021-11-19 | |||
| 2020-09-30 | $7.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-19 | $21.00M derived: sum of 2 quarters · filed 2021-11-19 | $34.00M derived: sum of 3 quarters · filed 2021-11-19 | $49.00M 10-K · filed 2021-11-19 | |
| 2020-06-30 | $14.00M 10-Q · filed 2020-08-04 | $27.00M derived: sum of 2 quarters · filed 2020-08-04 | $42.00M 10-Q · filed 2020-08-04 | ||
| 2020-03-31 | $13.00M 10-Q · filed 2020-05-07 | $28.00M 10-Q · filed 2020-05-07 | |||
| 2019-12-31 | $15.00M 10-Q · filed 2020-02-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUAKER CHEMICAL CORP (KWR) | United States | $2.747B | 27.94 |